The Spanish voiced obstruents /b d g/ are traditionally described as having each two allophones: stop and fricative (approximant) in complementary distribution. Several researchers have noted that some Central American and Highland Colombian varieties deviate from the general allophonic distribution in showing a preference for stop realizations in all contexts, except for the intervocalic position. In this paper we report on a large-scale acoustic investigation of /b d g/ in postconsonantal (after a liquid, sibilant or glide) and postvocalic (after /a/) contexts in Costa Rica Spanish, establishing a comparison with the variety of Madrid, Spain, which we take as representative of a variety with the general pattern of allophony. Our study, based on a continuous measurement of intensity, confirms previous descriptions in that Costa Rica Spanish does indeed show a different pattern of allophony from that found in the Madrid variety. The analysis shows that in Costa Rica Spanish postconsonantal realizations of /b/ and /d/ are very different from postvocalic ones, with a clear separation in the degree of constriction between these two contexts. In Madrid, on the other hand, we find a continuum of constriction degrees, depending on the nature of the specific preceding segment, and without a clear separation between postvocalic and postconsonantal realizations. The question that naturally arises is that of the historical connection between these two patterns of allophony, for which we offer some speculation, based in historical parallels and comparison with other varieties.

This content is only available via PDF.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.